Deep Medicine Acquisition Corp.
DMAQ · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -75.3% | 250.5% | 61% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 68% | 66.9% | 69.1% | 66.4% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -22.9% | -66.8% | 14% | -20.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -49.5% | -36.2% | -1% | -40.5% |
| EPS Diluted | -0.23 | -0.68 | -0.005 | -0.12 |
| % Growth | 66.2% | -15,011.1% | 96.2% | – |
| Operating Cash Flow | -$0 | -$0 | – | – |
| Capital Expenditures | -$0 | -$0 | – | – |
| Free Cash Flow | -$0 | -$0 | – | – |